NH vs SBI Healthcare Opportunities Fund

Portfolio Overlap Analysis · Nippon vs SBI

44.1%
High Overlap
11 common stocks · Rank #1901 of 28,282 pairs
Fund A
NH
Nippon · Equity - Other
Fund B
SBI Healthcare Opportunities Fund
SBI · Sectoral - Pharma

Common Holdings (10)

StockWt% in NHWt% in SBI Healthcare OpportunitiesOverlap
Sun Pharmaceutical Industries Limited
Pharmaceuticals & Biotechnology
21.93%10.65%10.65%
Divi's Laboratories Limited
Pharmaceuticals & Biotechnology
9.71%7.55%7.55%
Torrent Pharmaceuticals Limited
Pharmaceuticals & Biotechnology
5.40%4.25%4.25%
Lupin Limited
Pharmaceuticals & Biotechnology
6.65%4.23%4.23%
Laurus Labs Limited
Pharmaceuticals & Biotechnology
4.98%3.48%3.48%
Biocon Limited
Pharmaceuticals & Biotechnology
3.32%3.59%3.32%
Mankind Pharma Limited
Pharmaceuticals & Biotechnology
3.03%2.98%2.98%
Alkem Laboratories Limited
Pharmaceuticals & Biotechnology
3.93%2.77%2.77%
Gland Pharma Limited
Pharmaceuticals & Biotechnology
1.73%2.68%1.73%
Abbott India Limited
Pharmaceuticals & Biotechnology
1.65%1.95%1.65%

Unique to NH

  • Dr. Reddy's Laboratories Limited9.35%
  • Cipla Limited9.04%
  • Aurobindo Pharma Limited4.07%
  • Glenmark Pharmaceuticals Limited3.84%

Unique to SBI Healthcare Opportunities

  • Apollo Hospitals Enterprise Ltd.5.76%
  • Max Healthcare Institute Ltd.4.82%
  • Acutaas Chemicals Ltd.4.77%
  • Aster DM Healthcare Ltd.3.85%

Sector Overlap Breakdown

Pharmaceuticals & Biotechnology
44.1% (11)

Analysis

AI-generated comparative analysis coming soon.

More comparisons for NH

More comparisons for SBI Healthcare Opportunities

Overlap calculated on equity holdings only. Debt, government securities, and cash are excluded.